Hakenberg OW - Search Results

1

Immunohistochemical expression of retinoblastoma protein and p16 in renal cell carcinoma.

Maruschke M, Thur S, Kundt G, Nizze H, Hakenberg OW. Maruschke M, et al. Among authors: hakenberg ow. Urol Int. 2011;86(1):60-7. doi: 10.1159/000320510. Epub 2010 Sep 21. Urol Int. 2011. PMID: 20861610

2

Expression profiling of metastatic renal cell carcinoma using gene set enrichment analysis.

Maruschke M, Hakenberg OW, Koczan D, Zimmermann W, Stief CG, Buchner A. Maruschke M, et al. Among authors: hakenberg ow. Int J Urol. 2014 Jan;21(1):46-51. doi: 10.1111/iju.12183. Epub 2013 May 2. Int J Urol. 2014. PMID: 23634695

3

Copy Number Alterations with Prognostic Potential in Clear Cell Renal Cell Carcinoma.

Maruschke M, Koczan D, Ziems B, Hakenberg OW. Maruschke M, et al. Among authors: hakenberg ow. Urol Int. 2018;101(4):417-424. doi: 10.1159/000493149. Epub 2018 Sep 18. Urol Int. 2018. PMID: 30227442

4

Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread.

Maruschke M, Schmidt W, Casper J, Hakenberg OW. Maruschke M, et al. Among authors: hakenberg ow. Urol Int. 2008;81(1):119-21. doi: 10.1159/000137653. Epub 2008 Jul 16. Urol Int. 2008. PMID: 18645284

5

Is there an emerging role for neoadjuvant targeted therapy in renal cell carcinoma?

Maruschke M, Hakenberg OW. Maruschke M, et al. Among authors: hakenberg ow. Minerva Urol Nefrol. 2009 Jun;61(2):109-14. Minerva Urol Nefrol. 2009. PMID: 19451892 Review.

6

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ. Maruschke M, et al. Among authors: hakenberg ow. BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16. BJU Int. 2011. PMID: 21435154

7

Putative biomarker genes for grading clear cell renal cell carcinoma.

Maruschke M, Koczan D, Reuter D, Ziems B, Nizze H, Hakenberg OW, Thiesen HJ. Maruschke M, et al. Among authors: hakenberg ow. Urol Int. 2011;87(2):205-17. doi: 10.1159/000328196. Epub 2011 Jul 14. Urol Int. 2011. PMID: 21757870

8

TOP2A, HELLS, ATAD2, and TET3 Are Novel Prognostic Markers in Renal Cell Carcinoma.

Chen D, Maruschke M, Hakenberg O, Zimmermann W, Stief CG, Buchner A. Chen D, et al. Urology. 2017 Apr;102:265.e1-265.e7. doi: 10.1016/j.urology.2016.12.050. Epub 2017 Jan 6. Urology. 2017. PMID: 28069330

9

Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.

Zimpfer A, Maruschke M, Rehn S, Kundt G, Litzenberger A, Dammert F, Zettl H, Stephan C, Hakenberg OW, Erbersdobler A. Zimpfer A, et al. Among authors: hakenberg ow. BJU Int. 2014 Aug;114(2):296-302. doi: 10.1111/bju.12487. Epub 2014 Jan 15. BJU Int. 2014. PMID: 24215118

10

C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma.

Zimpfer A, Janke S, Hühns M, Schneider B, Kundt G, Zettl H, Kilic E, Maruschke M, Hakenberg OW, Erbersdobler A. Zimpfer A, et al. Among authors: hakenberg ow. Pathol Res Pract. 2014 Aug;210(8):521-5. doi: 10.1016/j.prp.2014.04.013. Epub 2014 May 4. Pathol Res Pract. 2014. PMID: 24875296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters